Gene · 5789
PTPRD: protein tyrosine phosphatase receptor type D
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PTPRD: protein tyrosine phosphatase receptor type D. Genes, record 5789. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5789
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P23468 | Receptor-type tyrosine-protein phosphatase delta | 1,912 | 8 | Ensembl, GeneID, HGNC |
Source UniProt
Patents75
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 60120 | P23468 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 60123 | P23468 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 60129 | P23468 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7293 | P23468 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7245 | P23468 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 11123 | P23468 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 11124 | P23468 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 11125 | P23468 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3637 | P23468 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7499 | P23468 | Espacenet |
1 to 10 of 75
See all 75 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,711
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PTPRD papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 32 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 18 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 11 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 7 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 6 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 6 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 5 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 5 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 4 | 2025 |
| P30CA045508 | CSHL Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,711Source NIH's project files
See all 1,711 nih grantsPapers1,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of novel loci regulating circulating melatonin and its causal relationship with hypertension. | Hum Genet | 2026 | 42565856 | PubTator, text mining | PubMed |
| Genome-Wide and Rare Variant Association Studies of Amblyopia in Admixed American and African Ancestry Groups. | Ophthalmology | 2026 | 42508771 | PubTator, text mining | PubMed |
| Asprosin-PTPRD endocrine resistance links brain dysfunction and systemic wasting in Alzheimer's disease. | Res Sq | 2026 | 42370281 | PubTator, text mining | PubMed |
| Primary multifocal gastrointestinal epithelioid angiosarcoma with MYC amplification: a diagnostic pitfall mimicking poorly differentiated carcinoma: a case report. | BMC Gastroenterol | 2026 | 42316027 | PubTator, text mining | PubMed |
| Comprehensive molecular analyses of a circadian rhythm-related gene diagnostic model and immune infiltration using machine learning methods in sepsis-associated acute kidney injury. | Hereditas | 2026 | 42277919 | PubTator, text mining | PubMed |
| Enhanced calcium activity and transcriptomic alterations in iPSC-derived neurons from BAFME patients with repeat expansions. | Neurosci Res | 2026 | 42276331 | PubTator, text mining | PubMed |
| Family-Based GWAS of Cognitive Endophenotypes Reveals Genetic Architecture of Memory and Executive Function in Alzheimer's Disease. | Curr Issues Mol Biol | 2026 | 42193047 | PubTator, text mining | PubMed |
| Single-nucleotide variants as potential prognostic biomarkers in newly diagnosed multiple myeloma patients. | Hematol Transfus Cell Ther | 2026 | 42068837 | PubTator, text mining | PubMed |
| Genetic role in autoimmune encephalitis and paraneoplastic neurological syndromes. | Curr Opin Neurol | 2026 | 42007814 | PubTator, text mining | PubMed |
| Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case report. | J Immunother Cancer | 2026 | 41986072 | PubTator, text mining | PubMed |
1 to 10 of 1,768
See all 1,768 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5789
GET https://conductscience.org/api/genes/v1/5789/patents?page=2